Correlations among insomnia symptoms, sleep medication use and depressive symptoms

Yoko Komada, Takashi Nomura, Masayoshi Kusumi, Kenji Nakashima, Isa Okajima, Taeko Sasai, Yuichi Inoue

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Aim: To elucidate the factors associated with insomnia symptoms and the use of sleep medication, and the correlations among insomnia symptoms, sleep medication use and depressive symptoms in the general population. Methods: This survey was conducted in a rural community of Japan. Questionnaires consisted of basic information, the Pittsburgh Sleep Quality Index, and a 12-item version of the Center for Epidemiological Studies Depression scale, and were administered to all community members aged 20 years or over. A total of 2822 respondents with valid answers were subjected to analysis. Results: Occurrence of insomnia symptoms appeared to be associated with advancing age and existence of depressive symptoms. The extent of sleep medication use in the entire sample was 9%, and the value in the subjects with insomnia symptoms was 26%. Sleep medication use in insomniacs was associated with female sex and advancing age as well as higher scores in subcomponents of both poor subjective sleep quality and prolonged delay of sleep onset. Depressive symptoms were worst in the group with insomnia symptoms using sleep medication, and were significantly lower in the group without insomnia symptoms using sleep medication. Conclusions: Our study revealed that female sex, advancing age, depressive symptoms, poor sleep quality, and prolonged delay of sleep onset appeared as risk factors for sleep medication use. Insomnia symptoms were suspected to act as an exacerbating factor for depressive symptoms. However, our findings suggested that appropriate use of sleep medication could reduce depressive symptoms in the subjects with insomnia symptoms.

Original languageEnglish
Pages (from-to)20-29
Number of pages10
JournalPsychiatry and Clinical Neurosciences
Volume65
Issue number1
DOIs
Publication statusPublished - 2011 Feb
Externally publishedYes

Fingerprint

Sleep Initiation and Maintenance Disorders
Sleep
Depression
Rural Population
Epidemiologic Studies
Japan

Keywords

  • depressive symptom
  • epidemiology
  • insomnia
  • sleep medication

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Komada, Y., Nomura, T., Kusumi, M., Nakashima, K., Okajima, I., Sasai, T., & Inoue, Y. (2011). Correlations among insomnia symptoms, sleep medication use and depressive symptoms. Psychiatry and Clinical Neurosciences, 65(1), 20-29. https://doi.org/10.1111/j.1440-1819.2010.02154.x

Correlations among insomnia symptoms, sleep medication use and depressive symptoms. / Komada, Yoko; Nomura, Takashi; Kusumi, Masayoshi; Nakashima, Kenji; Okajima, Isa; Sasai, Taeko; Inoue, Yuichi.

In: Psychiatry and Clinical Neurosciences, Vol. 65, No. 1, 02.2011, p. 20-29.

Research output: Contribution to journalArticle

Komada, Y, Nomura, T, Kusumi, M, Nakashima, K, Okajima, I, Sasai, T & Inoue, Y 2011, 'Correlations among insomnia symptoms, sleep medication use and depressive symptoms', Psychiatry and Clinical Neurosciences, vol. 65, no. 1, pp. 20-29. https://doi.org/10.1111/j.1440-1819.2010.02154.x
Komada, Yoko ; Nomura, Takashi ; Kusumi, Masayoshi ; Nakashima, Kenji ; Okajima, Isa ; Sasai, Taeko ; Inoue, Yuichi. / Correlations among insomnia symptoms, sleep medication use and depressive symptoms. In: Psychiatry and Clinical Neurosciences. 2011 ; Vol. 65, No. 1. pp. 20-29.
@article{99c7198d33d6413eb6139a71fc4a68bd,
title = "Correlations among insomnia symptoms, sleep medication use and depressive symptoms",
abstract = "Aim: To elucidate the factors associated with insomnia symptoms and the use of sleep medication, and the correlations among insomnia symptoms, sleep medication use and depressive symptoms in the general population. Methods: This survey was conducted in a rural community of Japan. Questionnaires consisted of basic information, the Pittsburgh Sleep Quality Index, and a 12-item version of the Center for Epidemiological Studies Depression scale, and were administered to all community members aged 20 years or over. A total of 2822 respondents with valid answers were subjected to analysis. Results: Occurrence of insomnia symptoms appeared to be associated with advancing age and existence of depressive symptoms. The extent of sleep medication use in the entire sample was 9{\%}, and the value in the subjects with insomnia symptoms was 26{\%}. Sleep medication use in insomniacs was associated with female sex and advancing age as well as higher scores in subcomponents of both poor subjective sleep quality and prolonged delay of sleep onset. Depressive symptoms were worst in the group with insomnia symptoms using sleep medication, and were significantly lower in the group without insomnia symptoms using sleep medication. Conclusions: Our study revealed that female sex, advancing age, depressive symptoms, poor sleep quality, and prolonged delay of sleep onset appeared as risk factors for sleep medication use. Insomnia symptoms were suspected to act as an exacerbating factor for depressive symptoms. However, our findings suggested that appropriate use of sleep medication could reduce depressive symptoms in the subjects with insomnia symptoms.",
keywords = "depressive symptom, epidemiology, insomnia, sleep medication",
author = "Yoko Komada and Takashi Nomura and Masayoshi Kusumi and Kenji Nakashima and Isa Okajima and Taeko Sasai and Yuichi Inoue",
year = "2011",
month = "2",
doi = "10.1111/j.1440-1819.2010.02154.x",
language = "English",
volume = "65",
pages = "20--29",
journal = "Psychiatry and Clinical Neurosciences",
issn = "1323-1316",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Correlations among insomnia symptoms, sleep medication use and depressive symptoms

AU - Komada, Yoko

AU - Nomura, Takashi

AU - Kusumi, Masayoshi

AU - Nakashima, Kenji

AU - Okajima, Isa

AU - Sasai, Taeko

AU - Inoue, Yuichi

PY - 2011/2

Y1 - 2011/2

N2 - Aim: To elucidate the factors associated with insomnia symptoms and the use of sleep medication, and the correlations among insomnia symptoms, sleep medication use and depressive symptoms in the general population. Methods: This survey was conducted in a rural community of Japan. Questionnaires consisted of basic information, the Pittsburgh Sleep Quality Index, and a 12-item version of the Center for Epidemiological Studies Depression scale, and were administered to all community members aged 20 years or over. A total of 2822 respondents with valid answers were subjected to analysis. Results: Occurrence of insomnia symptoms appeared to be associated with advancing age and existence of depressive symptoms. The extent of sleep medication use in the entire sample was 9%, and the value in the subjects with insomnia symptoms was 26%. Sleep medication use in insomniacs was associated with female sex and advancing age as well as higher scores in subcomponents of both poor subjective sleep quality and prolonged delay of sleep onset. Depressive symptoms were worst in the group with insomnia symptoms using sleep medication, and were significantly lower in the group without insomnia symptoms using sleep medication. Conclusions: Our study revealed that female sex, advancing age, depressive symptoms, poor sleep quality, and prolonged delay of sleep onset appeared as risk factors for sleep medication use. Insomnia symptoms were suspected to act as an exacerbating factor for depressive symptoms. However, our findings suggested that appropriate use of sleep medication could reduce depressive symptoms in the subjects with insomnia symptoms.

AB - Aim: To elucidate the factors associated with insomnia symptoms and the use of sleep medication, and the correlations among insomnia symptoms, sleep medication use and depressive symptoms in the general population. Methods: This survey was conducted in a rural community of Japan. Questionnaires consisted of basic information, the Pittsburgh Sleep Quality Index, and a 12-item version of the Center for Epidemiological Studies Depression scale, and were administered to all community members aged 20 years or over. A total of 2822 respondents with valid answers were subjected to analysis. Results: Occurrence of insomnia symptoms appeared to be associated with advancing age and existence of depressive symptoms. The extent of sleep medication use in the entire sample was 9%, and the value in the subjects with insomnia symptoms was 26%. Sleep medication use in insomniacs was associated with female sex and advancing age as well as higher scores in subcomponents of both poor subjective sleep quality and prolonged delay of sleep onset. Depressive symptoms were worst in the group with insomnia symptoms using sleep medication, and were significantly lower in the group without insomnia symptoms using sleep medication. Conclusions: Our study revealed that female sex, advancing age, depressive symptoms, poor sleep quality, and prolonged delay of sleep onset appeared as risk factors for sleep medication use. Insomnia symptoms were suspected to act as an exacerbating factor for depressive symptoms. However, our findings suggested that appropriate use of sleep medication could reduce depressive symptoms in the subjects with insomnia symptoms.

KW - depressive symptom

KW - epidemiology

KW - insomnia

KW - sleep medication

UR - http://www.scopus.com/inward/record.url?scp=79251563131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251563131&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1819.2010.02154.x

DO - 10.1111/j.1440-1819.2010.02154.x

M3 - Article

VL - 65

SP - 20

EP - 29

JO - Psychiatry and Clinical Neurosciences

JF - Psychiatry and Clinical Neurosciences

SN - 1323-1316

IS - 1

ER -